Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-08-27

Clinical Trial Update: BedMed-Frail: Does the Potential Benefit of Bedtime Antihypertensive Prescribing Extend to Frail Populations? [NA]

View source ↗

Summary

Completed clinical trial BedMed-Frail assessing whether bedtime antihypertensive prescribing benefits frail patients with hypertension and dementia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Alberta | Conditions: Hypertension, Dementia | NA | Status: COMPLETED